INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
Search

All disclosures

Every ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.

Results

Data sources
SEC Form 43h ago
House PTR3h ago
SEC 13F3h ago
Robinhood Chain3h ago

Results

78,781 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
WM
Wirfel MichelleEVP, Chief Operating Officer
BCALCalifornia BanCorp \ CA
Tax withholding
F$10K
595 sh
Mar 25, 2026Mar 26, 2026
Page 1277 of 1970
← PrevNext →
traded Mar 25, 2026
+1d
SEC Form 4

Evidence

9
CM
Cioffi Christiana MarieChief Strategy Officer
FENCFENNEC PHARMACEUTICALS INC.
Option exercise
M$20K
4,700 sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC Form 4

Evidence

9
CG
Ciongoli Adam G.Chief Legal and Policy Officer
FOXFox Corp
Grant or award
A—
128 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
JL
Johnson Margaret LDirector
FOXFox Corp
Grant or award
A$4,094
70 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
MV
Mitchell Adrian VDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$5,037
71 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
CA
Crew Debra AnnDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$8,917
126 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
BA
Burck William ADirector
FOXFox Corp
Grant or award
A$7,955
136 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
SC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
8,138 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
KL
Kirgan Danielle L.EVP, Chief HR Officer
MMacy's, Inc.
Option exercise
M—
8,539 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
YS
Yu SiyingGeneral Counsel
BABAAlibaba Group Holding Ltd
Option exercise
M—
25.3K sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
HD
Hankin Michael DavidDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$11K
155 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
XH
Xu HongChief Financial Officer
BABAAlibaba Group Holding Ltd
Option exercise
M—
62.0K sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
HD
Hankin Michael DavidDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$31K
442 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
KJ
Kihara JamesPRINCIPAL ACCOUNTING OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
2,142 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
CA
Crew Debra AnnDirector
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$10K
142 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
CG
Ciongoli Adam G.Chief Legal and Policy Officer
FOXFox Corp
Grant or award
A—
122 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
AJ
Abbott Anthony JDirector
FOXFox Corp
Grant or award
A$4,094
70 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
KA
Kampani ArjunSVP & General Counsel
RKLBRocket Lab Corp
Grant or award
A—
77.2K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
JB
Jenkins BrettSee Remarks
NXSTNEXSTAR MEDIA GROUP, INC.
Option exercise
M—
750 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
RD
Rush Stephen D.Chief Commercial Officer
ALITAlight, Inc. / Delaware
Grant or award
A—
3.75M sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
YS
Yu SiyingGeneral Counsel
BABAAlibaba Group Holding Ltd
Option exercise
M—
5,600 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
AJ
Ayers Andrea J.Director
SWKSTANLEY BLACK & DECKER, INC.
Grant or award
A$18K
248 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

9
JF
Jiang FangChief People Officer
BABAAlibaba Group Holding Ltd
Option exercise
M—
2,672 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
TM
Trotta MatteoEVP, GM, Dermatology US
INCYINCYTE CORP
Tax withholding
F$50K
537 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
VR
Verma RohitDirector, Chief Executive Officer
ALITAlight, Inc. / Delaware
Grant or award
A—
7.00M sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
SC
Schneyer Mark C.EVP, CHIEF FINANCIAL OFFICER
ACADACADIA PHARMACEUTICALS INC
Option exercise
M—
6,178 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

9
WS
Weaver Robert S.EVP, Government Relations
NXSTNEXSTAR MEDIA GROUP, INC.
Option exercise
M—
1,667 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

8
BE
Bowe Patrick E.Director
ANDEAndersons, Inc.
Open-market sale · 10b5-1 plan
SELL$58K
800 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

8
LR
Low RussellDirector, PRESIDENT AND CEO
ACLSAXCELIS TECHNOLOGIES INC
Open-market sale · 10b5-1 plan
SELL$112K
1,244 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

8
RD
Raben DavidChief Medical Officer
BCAXBicara Therapeutics Inc.
Open-market sale · 10b5-1 plan
SELL$104K
5,500 sh
Mar 25, 2026Mar 26, 2026
traded Mar 25, 2026
+1dSEC Form 4

Evidence

6
OD
Owens Bradley D.General Counsel
ZANDZGZILLOW GROUP, INC.
Option exercise · 10b5-1 plan
M$197K
8,800 sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

5
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Derivative conversion
C—
40.6K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

5
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Option exercise
M—
40.6K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

5
NA
Nithrakashyap ArvindDirector, Chief Technology Officer
RBRKRubrik, Inc.
Option exercise
M—
40.6K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

4
MA
Misra AmitabhChief Technology Officer
CXMSprinklr, Inc.
Open-market sale · 10b5-1 plan
SELL$243K
41.7K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

3
SG
Samuelson Errol GChief Industry Dev. Officer
ZANDZGZILLOW GROUP, INC.
Grant or award · 10b5-1 plan
A—
7,912 sh
Mar 26, 2026Mar 26, 2026
traded Mar 26, 2026
+0dSEC Form 4

Evidence

3
BA
Balcom AlexandraChief Financial Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$12K
11.4K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

3
BA
Balcom AlexandraChief Financial Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
11.4K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

3
RJ
Rubinstein JuliePresident and COO
ADPTAdaptive Biotechnologies Corp
Option exercise · 10b5-1 plan
M—
14.7K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence

2
CK
Choudary Kiran KumarChief Financial Officer
RBRKRubrik, Inc.
Option exercise
M—
212.2K sh
Mar 24, 2026Mar 26, 2026
traded Mar 24, 2026
+2dSEC Form 4

Evidence